These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2454810

  • 21. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ, Lautens LL, Tashjian AH.
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [Abstract] [Full Text] [Related]

  • 22. Modulation by 1,25-dihydroxycholecalciferol of the acute change in cytosolic free calcium induced by thyrotropin-releasing hormone in GH4C1 pituitary cells.
    Chisholm JC, Kim S, Tashjian AH.
    J Clin Invest; 1988 Mar; 81(3):661-8. PubMed ID: 2830313
    [Abstract] [Full Text] [Related]

  • 23. Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.
    Grimberg H, Zaltsman I, Lupu-Meiri M, Gershengorn MC, Oron Y.
    Br J Pharmacol; 1999 Mar; 126(5):1097-106. PubMed ID: 10204996
    [Abstract] [Full Text] [Related]

  • 24. Pituitary thyrotropin-releasing hormone (TRH) receptors: effects of TRH, drugs mimicking TRH action, and chlordiazepoxide.
    Hinkle PM, Shanshala ED.
    Mol Endocrinol; 1989 Sep; 3(9):1337-44. PubMed ID: 2481818
    [Abstract] [Full Text] [Related]

  • 25. Caffeine inhibits the binding of thyrotropin-releasing hormone in GH4C1 pituitary cells.
    Karhapää L, Törnquist K.
    Biochem Biophys Res Commun; 1995 May 25; 210(3):726-32. PubMed ID: 7539257
    [Abstract] [Full Text] [Related]

  • 26. Pituitary thyrotropin-releasing hormone receptors: local anesthetic effects on binding and responses.
    Phillips WJ, Enyeart JJ, Hinkle PM.
    Mol Endocrinol; 1989 Sep 25; 3(9):1345-51. PubMed ID: 2558307
    [Abstract] [Full Text] [Related]

  • 27. Central and peripheral type benzodiazepine ligands displace [3H][3-ME-HIS2]TRH from its binding sites in the brain and the anterior pituitary and antagonize the effect of TRH in the rat duodenum.
    Järvinen A, Paakkari I, Männistö PT.
    Neuropeptides; 1991 Jul 25; 19(3):147-55. PubMed ID: 1654530
    [Abstract] [Full Text] [Related]

  • 28. Use of receptor antagonist in elucidating the mechanism of action of TRH in GH3 cells.
    Drummond AH, Hughes PJ, Ruiz-Larrea F, Joels LA.
    Ann N Y Acad Sci; 1989 Jul 25; 553():197-204. PubMed ID: 2566295
    [No Abstract] [Full Text] [Related]

  • 29. Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells.
    Brenner-Gati L, Gershengorn MC.
    Endocrinology; 1986 Jan 25; 118(1):163-9. PubMed ID: 3000732
    [Abstract] [Full Text] [Related]

  • 30. Calcium influx is not required for thyrotropin-releasing hormone stimulation of prolactin release from GH3 cells.
    Gershengorn MC, Thaw C, Gerry RH.
    Cell Calcium; 1983 Apr 25; 4(2):117-24. PubMed ID: 6409414
    [Abstract] [Full Text] [Related]

  • 31. Thyrotropin-releasing hormone causes loss of cellular calcium without calcium uptake by rat pituitary cells in culture. Studies using arsenazo III for direct measurement of calcium.
    Rebecchi MJ, Gerry RH, Gershengorn MC.
    J Biol Chem; 1982 Mar 25; 257(6):2751-3. PubMed ID: 6801036
    [Abstract] [Full Text] [Related]

  • 32. Preferential role of calcium in the regulation of prolactin gene transcription by thyrotropin-releasing hormone in GH3 pituitary cells.
    Laverriere JN, Tixier-Vidal A, Buisson N, Morin A, Martial JA, Gourdji D.
    Endocrinology; 1988 Jan 25; 122(1):333-40. PubMed ID: 2446857
    [Abstract] [Full Text] [Related]

  • 33. Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries.
    Roussel JP, Astier H, Tapia-Arancibia L.
    Endocrinology; 1986 Dec 25; 119(6):2519-26. PubMed ID: 3023014
    [Abstract] [Full Text] [Related]

  • 34. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
    McDermott AM, Wilkin GP, Dickinson SL.
    Br J Pharmacol; 1990 Nov 25; 101(3):615-20. PubMed ID: 1963801
    [Abstract] [Full Text] [Related]

  • 35. The coumarin osthol attenuates the binding of thyrotropin-releasing hormone in rat pituitary GH4C1 cells.
    Ojala T, Vuorela P, Vuorela H, Törnquist K.
    Planta Med; 2001 Apr 25; 67(3):236-9. PubMed ID: 11345694
    [Abstract] [Full Text] [Related]

  • 36. Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
    Phillips WJ, Hinkle PM.
    Mol Pharmacol; 1989 Apr 25; 35(4):533-40. PubMed ID: 2539560
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells.
    Smallridge RC, Kiang JG, Gist ID, Fein HG, Galloway RJ.
    Endocrinology; 1992 Oct 25; 131(4):1883-8. PubMed ID: 1396332
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.